In a still-dodgy fundraising arena, the question for biotechs looking for royalty-stream financing is this: How much will you have to give i...

We've survived BIO and most of us are home, ready to relax after a loooooong week. But before you sign off, enjoy our favorite off-topic...

The motto of the biotech industry's trade organization is "Heal, Fuel, Feed the World," and the group could start by getting u...

One theme we keep hearing in Chicago this week is that early-stage startups, too young to attract serious pharma partnerships and struggling...

The Centers for Medicare & Medicaid Services is facing a bit of pressure to close a potential “loophole” in its implementation of the do...

There’s a bit of buzz in Washington, DC about a “loophole” in the brand name pharmaceutical industry’s 50% discount for Medicare beneficiari...

After hosting a steady stream of panels on biotech-pharma in-licensing over the years, biotech lawyer Barbara Kosacz put it in reverse at BI...

Greetings from Chicago! Fantastic weather for early May, an economy on the upswing, not to mention a certain conference that's in town, ...

Evaluate Pharma is one of numerous pharma consulting firms to publish its own sweep of the biopharma industry in conjunction with BIO; in th...

What, you thought we’d go all Sarah Palin on you? We're guessing the phrase “Drill, baby, drill!” is about as popular as that oil slic...